| AREAS
OF EXPERTISE |
| Experienced
in the preparation of: |
| |
- Summaries of Clinical Safety for New Drug Applications
(NDAs)/Biologics License Applications (BLAs),
- Clinical
study reports,
- Clinical
study protocols,
- Investigational
New Drug (IND) Annual Reports,
- Investigator
brochures and
- Informed
consent documents
|
- Proficient in the use of the International Conference
on Harmonisation (ICH) Common Technical Document
(CTD) format;
- Trained
Good Clinical Practice (GCP) auditor;
- Provides
safety data management services such as receiving,
assessing, coding and preparing regulatory reports
on emerging clinical trial safety data;
- Trained
user of the European Agency for the Evaluation
of Medicinal Products (EMEA) EudraVigilance
safety database and ArisGlobal
|
|
EDUCATION
| ND |
|
Doctor
of Nursing, University of Colorado, Denver, CO (1999) |
| MSN |
|
Master
of Science in Nursing, Family Nurse Practitioner Program,
University of Colorado, Denver, CO (2001) |
| BA |
|
University
of Maine, Portland, ME (1989) |
EXPERIENCE:
CURRENT
POSITION:
Jan. 2005 - Present |
|
Consultant,
Biologics Consulting Group, Inc.
Nederland, CO.
- Clinical consultant working with drugs and biologics
in Phases I through III of development;
- Medical
writer with responsibility for analyzing and summarizing
large, complex safety and efficacy data sets from
clinical trials;
- Evaluate
and provide input on Statistical Analysis Plans (SAPs)
for individual clinical studies and pooled clinical
data sets;
- Specialize
in the preparation of Integrated Summary of Safety
(ISS) and
- Summary
of Clinical Safety (SCS) documents for Biologics License
Applications (BLAs) and New Drug Applications (NDAs);
- Experienced
in the preparation of clinical study protocols, clinical
study reports, informed consent documents, IND Annual
Reports, Investigator Brochures, IND
- Safety
Reports
- Provide
pharmacovigilance consulting services including serious
adverse event processing plans, design and implementation
of pharmacovigilance systems, and processing/reporting
of SAEs
- Provide
auditing services including GCP and Pharmacovigilance
systems audits
|
| |
|
|
| Jul
2002 - Dec. 2004 |
|
Clinical
Safety Associate II, OSI Pharmaceuticals, Boulder,
CO.
- Worked
with six products in Phases I through III of development
- Received,
assessed, processed, and queried serious adverse event
reports
- Prepared
and submited expedited reports, analyses of similar
events and investigator letters
- Assisted
in data quality planning, CRF design, protocol review,
informed consent preparation, and writing clinical
study reports
- Worked
closely with Regulatory and Clinical Departments,
development partners, CROs and regional medical monitors
to ensure timely and accurate reporting of clinical
trial safety data
- Prepared
periodic safety summaries, analyses, safety sections
of IND Annual Reports and Investigator Brochures,
and updated the development core safety information
(DCSI) for these products
- Performed
database reconciliation, coding review and query generation
- Authored
departmental SOPs and guidelines
|
| |
|
|
| Jan.
2002 - Jan. 2004 |
|
Clinical
Safety Specialist/Consultant, Sirna Therapeutics/Ribozyme
Pharmaceuticals, Boulder, CO.
- Performed
all clinical safety data management activities for
company
- Worked
closely with Clinical, Biostatistics and Regulatory
staff on protocol development, adverse event data
collection planning, preparation of regulatory submissions,
querying and data cleaning
- Responsible
for preparation of SAE form and instructions, safety
section of IND Annual Reports, Investigator Brochures,
ad hoc safety summaries and materials for Investigator
meetings
- Assisted
in the identification of a safety signal and in notification
of regulators and investigators
|
| |
|
|
| May
2001 - Jan. 2002 |
|
Professional
Research Associate, University of Colorado School
of Medicine, Denver, CO.
- Acted
as a study coordinator for three ongoing clinical
trials
- Assessed,
treated and managed pulmonary hypertension patients,
including performing study-related assessments
- Assisted
in development of an investigator-sponsored protocol,
designing the case report form, and creation of the
study database
- Submitted
protocols and informed consent documents to the local
Institutional Review Board
|
| |
|
|
| Jan.
2000 - May 2001 |
|
Homeless
Outreach Program, The People's Clinic, Boulder, CO.
- Co-created
and managed a new homeless outreach nursing program
- Nurse
case-managed medically fragile, homeless patients
- Created
and maintained a program utilization database
|
| |
|
|
| Sept.
1997 - Dec. 1999 |
|
Clinical
Instructor, Jan. 1999 to Dec. 1999, Doctoral Resident
and Research Fellow, Sept. 1997 to Jan. 1999, University
of Colorado School of Nursing, Denver, CO.
- Completed
an IRB-approved correlational study of 208 homeless
women, regarding the relationship between their physical
and mental health, substance abuse, family status
and history of exposure to violence
- Trained
doctoral residents and nursing students
- Assisted
in creating a clinic and medical case management program
|
| |
|
|
| 1995
- 2001 |
|
Family
Nurse Practitioner Program, 1999 to 2001, Nursing Doctorate
Program, 1995 to 1999, University of Colorado Health
Sciences Center, Denver, CO
- Full-time
graduate nursing student, completing over 3,000 hours
of direct patient care and 1,000 hours of research
during the period
- National
Health Service Corps Fellow, 1996
|
CONTINUING
EDUCATION
| 2008 |
Analysis of Safety Data from Clinical Trials (Drug Information Association) |
| 2008 |
Writing in the Medical Sciences (Graham School, University of Chicago) |
| 2007 |
Interpreting
and Reporting Biostatistics (Graham School, University
of Chicago) |
| 2006 |
Risk
Management and Pharmacovigilance (DIA) |
| 2005 |
GCP
Auditing, Drug Information Association (DIA) |
| 2004 |
Good
Clinical Practice Training, CBR International |
| 2004 |
EudraVigilance
User Training, DIA/EMEA |
| 2004 |
Principles
of Molecular Oncology, ASCO |
| 2003 |
Mt
Sinai School of Medicine Chemotherapy Symposium |
| 2003 |
DIA
Annual Meeting, San Antonio, Texas |
| 2002 |
Clinical
Trial Drug Safety Assessment, PERI |
| 2002 |
Clinical
Drug Development 101, Drug Development Consulting |
| 2002 |
MedDRA:
An Introduction, Integrated Safety Systems |
PROFESSIONAL
ASSOCIATIONS
| 2004
- present |
|
Member,
American Medical Writers Association |
| 2002
- present |
|
Member,
Drug Information Association |
Page
Updated:
July 3, 2008
|